Detalhe da pesquisa
1.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931632
2.
Breast Cancer Survivorship: the Role of Rehabilitation According to the International Classification of Functioning Disability and Health-a Scoping Review.
Curr Oncol Rep
; 24(9): 1163-1175, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403973
3.
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials.
BMC Cancer
; 21(1): 549, 2021 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33985435
4.
A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system.
Support Care Cancer
; 29(6): 3219-3233, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094357
5.
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
Int J Gynecol Cancer
; 31(6): 875-882, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931498
6.
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial.
Int J Gynecol Cancer
; 31(10): 1348-1355, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462317
7.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
J Transl Med
; 18(1): 405, 2020 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087150
8.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol
; 154(1): 83-88, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31029508
9.
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
Gynecol Oncol
; 153(3): 535-540, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30979589
10.
Pembrolizumab in lung cancer: current evidence and future perspectives.
Future Oncol
; 15(29): 3327-3336, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31432705
11.
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial.
Gynecol Oncol
; 144(2): 256-259, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27993479
12.
Angiogenesis Inhibitors in NSCLC.
Int J Mol Sci
; 18(10)2017 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28934120
13.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
J Transl Med
; 19(1): 442, 2021 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34674735
14.
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).
BMC Cancer
; 16: 69, 2016 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26857924
15.
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 16(5): 561-8, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25882986
16.
EGFR mutations in lung cancer: from tissue testing to liquid biopsy.
Future Oncol
; 11(11): 1611-23, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26043215
17.
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 15(4): 396-405, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24582486
18.
Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).
BMC Cancer
; 14: 875, 2014 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25421252
19.
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study.
Lancet Reg Health Eur
; 41: 100912, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38665620
20.
Risk Management Activities in a Lung Cancer Multidisciplinary Team at a Comprehensive Cancer Center: Results of a Prospective Analysis.
JCO Oncol Pract
; 19(3): e315-e325, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36383923